Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Volpara Health Technologies.
RELATED STOCKHEAD STORIES
Experts
Why the Aussie dollar matters, and which ASX stocks are exposed to its movements
Health & Biotech
ScoPo’s Powerplays: ASX health stocks sprout 4.6%, as Volpara soars on first positive cash flow
Health & Biotech
Check Up: Japan’s startup OUI wants to halve the world’s blindness with its smartphone device
News
ASX Earnings Wrap: Redbubble sinks 11pc on outlook; QuickFee and Volpara gain momentum
Health & Biotech
ScoPo’s Powerplays: Volpara leads a minor ASX small cap health sector renaissance
Health & Biotech
ASX Health Stocks: LBT Innovations picked by AstraZeneca as partner, share price surges 22pc
News
Market Highlights: Bull investors back after US jobs numbers, and 5 ASX small caps to watch on Monday
Health & Biotech
ScoPo’s Powerplays: ASX health stocks fall as Mach7 lands its biggest customer yet
Health & Biotech
ScoPo’s Powerplays: Health sector rattled but ASX X-ray stocks dance, led by boss PME up 28% since June
Experts
After scaring everyone in 2022 it looks like ASX health stocks will have a pulse in 2023
Health & Biotech
ScoPo’s Powerplays: ASX health stocks seek some end of year love
Health & Biotech
ScoPo’s Powerplays: Is it time to fill the Christmas stocking early with some ASX health stocks?
Tech
Recurring revenue: Why investors love it and which ASX SaaS stocks topped last quarter
News
ASX Quarterlies: Records are already tumbling and we haven’t even had the Opening Ceremony yet
Experts
MoneyTalks: Get your portfolio in rude health with these 3 ASX life science stocks
Experts
ScoPo’s Powerplays: ASX health stocks catch a strong bid in July rally
News
